$12.9 Million is the total value of March Altus Capital Management LP's 8 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 33.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ACAD | Buy | ACADIA PHARMACEUTICALS INC | $2,685,000 | +345.3% | 82,723 | +283.8% | 20.75% | +232.6% |
LLY | LILLY ELI & CO | $2,111,000 | +9.3% | 26,810 | 0.0% | 16.32% | -18.3% | |
EW | Buy | EDWARDS LIFESCIENCES CORP | $1,856,000 | +20.6% | 18,611 | +6.7% | 14.35% | -9.9% |
JNJ | New | JOHNSON & JOHNSON | $1,577,000 | – | 13,000 | +100.0% | 12.19% | – |
ALGN | Buy | ALIGN TECHNOLOGY INC | $1,395,000 | +257.7% | 17,319 | +222.8% | 10.78% | +167.2% |
PETX | ARATANA THERAPEUTICS INC | $1,381,000 | +14.5% | 218,515 | 0.0% | 10.68% | -14.4% | |
ALXN | ALEXION PHARMACEUTICALS INC | $1,004,000 | -16.1% | 8,599 | 0.0% | 7.76% | -37.3% | |
DXCM | Sell | DEXCOM INC | $928,000 | -28.2% | 11,700 | -38.6% | 7.17% | -46.4% |
ATHN | Exit | ATHENAHEALTH INC | $0 | – | -4,900 | -100.0% | -7.04% | – |
REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -2,291 | -100.0% | -8.55% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-07-27
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
DEXCOM INC | 12 | Q3 2016 | 14.4% |
LILLY ELI & CO | 12 | Q3 2016 | 20.0% |
ALEXION PHARMACEUTICALS INC | 11 | Q3 2016 | 15.1% |
MALLINCKRODT PUB LTD CO | 8 | Q3 2015 | 7.0% |
UNITED THERAPEUTICS CORP DEL | 7 | Q3 2015 | 11.7% |
REGENERON PHARMACEUTICALS | 7 | Q3 2016 | 14.6% |
UNIVERSAL HLTH SVCS INC | 7 | Q2 2015 | 12.1% |
ZOETIS INC | 7 | Q3 2016 | 5.2% |
INCYTE CORP | 6 | Q4 2015 | 14.7% |
EDWARDS LIFESCIENCES CORP | 5 | Q3 2016 | 28.5% |
View March Altus Capital Management LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2016-11-07 |
13F-HR | 2016-07-27 |
13F-HR | 2016-05-12 |
13F-HR | 2016-02-16 |
13F-HR | 2015-11-16 |
13F-HR | 2015-08-14 |
13F-HR | 2015-05-15 |
13F-HR | 2015-02-17 |
13F-HR | 2014-11-14 |
13F-HR | 2014-08-14 |
View March Altus Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.